WUXI NEWS

Dr. Ge Li Recognized as “The 25 Most Influential People in Biopharma in 2015”

Dr. Ge Li Recognized as “The 25 Most Influential People in Biopharma in 2015”

FierceBiotech, a leading daily monitor of the global biotech industry, announced recently its much anticipated “The 25 Most Influential People in Biopharma in 2015”.  Dr. Ge Li, our Chairman and CEO, is distinguished on the list for “Changing the face of Chinese R&D”.  Read more.

WuXi Launches e-Commerce Platform for Chemistry Products

WuXi Launches e-Commerce Platform for Chemistry Products

LabNetwork is a eCommerce platform for connecting buyers and sellers of research chemicals and reagents.  Read more.

WuXi V-Lab App Releases Version 2.0 with New Interface and Payment Feature

WuXi V-Lab App Releases Version 2.0 with New Interface and Payment Feature

We are thrilled to announce the Version 2.0 update of WuXi V-Lab with  a fresh new look.  Read more.

WuXi Biologics Begins Construction of the World’s Largest Mammalian Cell Culture Manufacturing Facility Using Disposable Bioreactors
WuXi Joins Consortium to Acquire Ambrx

WuXi Joins Consortium to Acquire Ambrx

We are pleased to share with you that WuXi has joined a consortium to acquire Ambrx, a San Diego based innovative biotech company.  Read more.

---

FDA APPROVALS AND DESIGNATIONS

Email us at communications@wuxiapptec.com for your important clinical milestones and we will share it with our community. 

---
---

Thank you for your support in helping WuXi reach where we are today. We will continue with our goal - to serve you better with our integrated technology and capability platform.
 Office of Corporate Communications, WuXi AppTec

Web: www.wuxiapptec.com/wxpress | Email: communications@wuxiapptec.com